Current updates on generations, approvals, and clinical trials of CAR T-cell therapy
T Asmamaw Dejenie, M Tiruneh G/Medhin… - Human Vaccines & …, 2022 - Taylor & Francis
Chimeric antigen receptor (CAR) T-cell therapy is a novel, customized immunotherapy that
is considered a 'living'and self-replicating drug to treat cancer, sometimes resulting in a …
is considered a 'living'and self-replicating drug to treat cancer, sometimes resulting in a …
Essentials of CAR-T Therapy and Associated Microbial Challenges in Long Run Immunotherapy
Chimeric antigen receptor (CAR)-T cell therapy has shown potential in improving outcomes
for individuals with hematological malignancies. However, achieving long-term full …
for individuals with hematological malignancies. However, achieving long-term full …